42 CFR Part 2

Slide deck from July 2024 presentation to NASADAD membership, during which the CoE-PHI outlined recent changes to Part 2, the federal law that protects the confidentiality of substance use disorder (SUD) treatment records, and applied learning to common scenarios through interactive case studies. Considerations for next steps for state and municipal agency leaders regarding implementation of recent changes to Part 2 were also highlighted and discussed.

During this webinar, we outlined recent changes to Part 2, the federal law that protects the confidentiality of substance use disorder (SUD) treatment records, and applied learning to common scenarios through interactive case studies. During the webinar, considerations for next steps regarding implementation of recent changes to the law were also discussed.

This module is designed to help professionals who provide or administer substance use disorder related services identify what constitutes a medical emergency, and describes who may receive records pursuant to the medical emergency exception under Part 2.

On February 8, 2024, HHS, through SAMHSA and OCR, announced final rule changes to 42 CFR Part 2 (“Part 2”), the federal law that protects the confidentiality of substance use disorder (SUD) treatment records. This HHS Fact Sheet provides further information about the final rule changes.

Archived recording of May 2023 webinar facilitated by the CoE-PHI to explain how the federal health privacy regulations apply to medications for opioid use disorder (MOUD) in correctional entities, especially jails, prisons, and detention centers. This webinar includes common scenarios in which patient information may or may not be shareable, and assists learners in determining the proper course of action for each scenario.

The federal confidentiality protections for substance use disorder (SUD) treatment records under 42 CFR Part 2 generally require a patient’s written consent to share information. Providers often have questions about how to fill out a consent form that authorizes disclosures to multiple parties in a way that complies with Part 2 and the HIPAA Privacy Rule.